Acute myeloid leukemia
Adenosine A2A receptor
Adenosine A2B receptor
Antigen presenting cells
AstraZeneca
Autoimmunity
Avelumab
B7-H3
BTLA
Bristol-Myers Squibb
CD137
CD154
CD27
CD278
CD28
CD40
CD70
CD80
CD86
CTLA-4
CTLA4
Cancer immunotherapy
Ceplene
Checkpoint inhibitor
ClinicalTrials.gov
Doi (identifier)
EU
GITR
HAVCR2
HER2
Hoffmann-La Roche
IL-2 receptor
IL2RB
ISBN (identifier)
ISSN (identifier)
Immune system
Indoleamine 2,3-dioxygenase
Ipilimumab
James P. Allison
Killer-cell immunoglobulin-like receptor
LAG3
LGALS9
Lipocalin
MHC Class I
Merck & Co.
Monoclonal antibody
Myeloid cells
NADPH
NK cells
NOX2
Natural Killer cell
Nektar Therapeutics
Nobel Prize in Physiology or Medicine
OX40
Open access
PD-1
PD-L1
PD-L2
PMC (identifier)
PMID (identifier)
Pembrolizumab
Pfizer
Reactive oxygen species
S2CID (identifier)
SIGLEC7
SIGLEC9
Self-tolerance
TGN1412
TNF receptor superfamily
T cells
Tang Prize
Tasuku Honjo
Th17
VISTA (protein)
VTCN1